Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2025-01-31 Board/Management Inform…
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Sameer Badlani - Optomed - CV - 2025.pdf
Board/Management Information Classification · 95% confidence The document is a Curriculum Vitae (CV) for an individual named Sameer Badlani, detailing his education, professional history, and positions of trust. This type of document is typically provided as part of a board nomination or management disclosure package. Since it does not fit into specific financial reporting categories like 10-K, ER, or IR, and is not an announcement of a report, it falls under the general regulatory/corporate disclosure category.
2025-01-31 English
Optomedin osakkeenomistajien nimitystoimikunnan ehdotus
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proposal from the Shareholders' Nomination Committee regarding the upcoming Annual General Meeting (AGM). It outlines nominations for the Board of Directors, proposed board remuneration, and the composition of the committee. This type of document is typically distributed to shareholders as part of the proxy materials or preparatory information for an AGM, falling under the category of Proxy Solicitation & Information Statement.
2025-01-31 Finnish
Leana Wen - Optomed - CV - 2025.pdf
Board/Management Information Classification · 95% confidence The document is a Curriculum Vitae (CV) for an individual named Leana Wen, detailing her education, current positions, previous positions, and positions of trust. This type of document is typically provided as part of a board nomination or director profile disclosure within a company's governance or proxy materials. Since it does not fit into specific financial reporting categories like 10-K or ER, and is not an announcement of a report, it falls under the general regulatory/governance disclosure category.
2025-01-31 English
Sameer Badlani - Optomed - CV - 2025.pdf
Board/Management Information Classification · 95% confidence The document is a Curriculum Vitae (CV) for an individual named Sameer Badlani, detailing his education, professional history, and positions of trust. This type of document is typically provided as part of a board nomination or management disclosure package. Since it does not fit into specific financial reporting categories like 10-K, ER, or IR, and is not an announcement of a report, it falls under the general regulatory/corporate disclosure category.
2025-01-31 English
Proposal of Optomed's Nomination Board
AGM Information Classification · 98% confidence The document is a 'Stock Exchange Release' from Optomed Plc detailing the proposals of the Nomination Board regarding the composition and remuneration of the Board of Directors for the upcoming Annual General Meeting. This type of document, which outlines board nominations and compensation proposals ahead of a shareholder meeting, is classified as Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on board-related matters.
2025-01-31 English
Optomedin osakkeenomistajien nimity..
Board/Management Information Classification · 99% confidence The document text consists almost entirely of a detailed curriculum vitae (CV) or biography for an individual named Leana Wen, listing her education, current positions, previous positions, and key positions of trust (including several Independent Board Member roles for corporations like Glaukos Corporation and UroGen Pharma). This type of detailed disclosure regarding director qualifications, background, and potential conflicts of interest is a core component of materials related to director nominations, elections, or compensation. Given the options, this information is most closely associated with the materials required for shareholder meetings concerning board composition and director elections. The most fitting category is 'Remuneration Information' (DEF 14A), which covers director compensation and related disclosures, or potentially 'Governance Information' (CGR). However, detailed director profiles are standard inclusions in Proxy Statements (DEF 14A/PSI). Since this is a profile of a director/potential director, and not a general governance report, DEF 14A (Remuneration Information, often bundled with director election materials) is the strongest fit, although PSI (Proxy Solicitation) is also highly relevant. Since the document focuses purely on the individual's qualifications and roles, and not the voting mechanics or remuneration amounts directly, Governance Information (CGR) is a strong candidate for general board structure/qualification disclosure. However, in the context of US filings, detailed director bios are mandatory for DEF 14A (Proxy Statement/Information Statement). I will select DEF 14A as the primary classification for detailed director/management background disclosure.
2025-01-31 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.